Catalyst Wire Dossier Catalyst Wire Dossier

WJ-derived mesenchymal stem cells

mesenchymal stem cells derived from Wharton's jelly
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for WJ-derived mesenchymal stem cells, covering 2021-08-24 to 2021-08-24. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy of WJ-derived Mesenchymal Stem Cells in Combination With Parathyroid Hormone for Vertebral Compression Fracture [Phase 2]

See pricing